Indirect Genotoxicity in Metal Carcinogenesis
金属致癌过程中的间接遗传毒性
基本信息
- 批准号:9913735
- 负责人:
- 金额:$ 36.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-15 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AlloysAnabolismBindingBiochemical ProcessBiological AssayBiological MarkersCancer EtiologyCancer ModelCancerousCarcinogenicity TestsCarcinogensCell CycleCellsChemicalsChemopreventionChemopreventive AgentChromosome Fragile SitesChromosome abnormalityDNADNA AdductsDNA DamageDNA Sequence AlterationDNA replication forkDangerousnessDependenceDevelopmentDoseEarly DiagnosisEnvironmentEnvironmental PollutantsEnzymesEventExposure toFiberFossil FuelsGeneticGenomeGenomicsGenotoxic StressGoalsHumanImpairmentIncinerationIndividualIndustrializationInhalation ExposureKnowledgeLungLung NeoplasmsMalignant NeoplasmsMalignant neoplasm of lungMetabolic dysfunctionMetabolismMetal CarcinogenesisMetalsMethodologyModelingMolecular AbnormalityMunicipalitiesMutagensMutationNickelOccupational ExposureOncogenicPharmaceutical PreparationsPhenotypePhosphotransferasesPlayPopulationPredispositionProcessProductionPublic HealthRRM1 geneRRM2 geneRepressionResearchRibonucleotide ReductaseRiskRisk AssessmentRodentRoleS PhaseSignal TransductionSiteSourceSpecificityStainless SteelStructureSuperfundTestingThymidylate SynthaseTumor Suppressor GenesWorkbasecancer riskcarcinogenicitycell transformationchromium hexavalent ionepidemiologic dataexperimental studygenotoxicityimprovedmelanomanovelpotential biomarkertumorigenicwasting
项目摘要
Project Summary
Mutations in various oncogenes and tumor-suppressor genes as well as other genome rearrangements
are a principal cause of human cancers. Lung tumors have especially high burdens of mutations.
Despite this dependence of cancer development on multiple genetic events, many human lung
carcinogens are tested as nonmutagenic in standard assays. Our current lack of knowledge about the
causes of genetic damage by seemingly nonmutagenic carcinogens negatively impacts public health
actions and precludes early detection of this class of dangerous chemicals. Metals is one important
group of widespread carcinogens that are largely nonmutagenic, including lung cancer-causing nickel
(Ni). Ni is a large-volume industrial metal with inhalation exposures occurring daily among millions of
workers. This metal is also a common environmental pollutant that is abundantly released during fossil
fuel burning, incineration of municipal waste and many other processes. Ni is found at > 50% of
Superfund toxic sites. In this project, we will test a conceptually novel hypothesis that Ni(II) disrupts a
unique biochemical process and the resulting metabolic dysfunction causes gross genetic alterations
and cancerous transformation of human lung cells. Our main hypothesis will be tested in three
complementary aims. The proposed studies will determine (1) mechanisms of Ni(II)-induced changes
in cell metabolites, (2) initial and secondary genetic abnormalities resulting from Ni(II)-altered
metabolism and protective functions of ATR kinase, and (3) importance of Ni-induced metabolic
dysfunction in tumorigenic cell transformation. The completion of the proposed work is expected to
establish a novel mechanism for indirect genotoxicity by a major human carcinogen. This mechanism
can be applicable to other nonmutagenic carcinogens possessing a specific chemical reactivity. The
project should also provide a valuable mechanistic information needed for modeling of cancer risks at
low-dose Ni exposures and identify targets for development of potential chemopreventive approaches.
项目摘要
各种癌基因和肿瘤抑制基因的突变以及其他基因组重排
是人类癌症的主要原因。肺肿瘤具有特别高的突变负担。
尽管癌症的发展依赖于多种遗传事件,但许多人的肺
致癌物在标准试验中被测试为非诱变性的。我们目前缺乏关于
看似非诱变性致癌物造成遗传损伤的原因对公众健康产生负面影响
采取行动并排除此类危险化学品的早期检测。金属是一种重要的
一组广泛存在的致癌物,大部分无诱变性,包括导致肺癌的镍
(Ni).镍是一种大容量的工业金属,每天有数百万人吸入镍。
工人这种金属也是一种常见的环境污染物,在化石过程中大量释放
燃料燃烧、城市垃圾焚烧和许多其他过程。发现Ni为> 50%,
超级基金有毒网站。在这个项目中,我们将测试一个概念新颖的假设,Ni(II)破坏了一个
独特的生物化学过程和由此产生的代谢功能障碍导致总的遗传改变
以及人类肺细胞的癌变。我们的主要假设将在三个方面得到检验
互补的目标。拟开展的研究将确定(1)Ni(II)诱导变化的机制
在细胞代谢产物中,(2)由Ni(II)改变的
ATR激酶的代谢和保护功能,以及(3)镍诱导的代谢的重要性
致瘤细胞转化功能障碍。预计拟议工作完成后,
建立了一种主要人类致癌物间接遗传毒性的新机制。这一机制
可适用于具有特定化学反应性的其他非致突变致癌物。的
项目还应提供一个有价值的机制信息,需要为癌症风险建模,
低剂量镍暴露,并确定潜在的化学预防方法的发展目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anatoly Zhitkovich其他文献
Anatoly Zhitkovich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anatoly Zhitkovich', 18)}}的其他基金
Indirect Genotoxicity in Metal Carcinogenesis
金属致癌过程中的间接遗传毒性
- 批准号:
10527323 - 财政年份:2020
- 资助金额:
$ 36.56万 - 项目类别:
Indirect Genotoxicity in Metal Carcinogenesis
金属致癌过程中的间接遗传毒性
- 批准号:
10304906 - 财政年份:2020
- 资助金额:
$ 36.56万 - 项目类别:
Regulation of p53 and Checkpoint Signaling by Chromium(VI)
Chromium(VI) 对 p53 和检查点信号传导的调节
- 批准号:
10306386 - 财政年份:2017
- 资助金额:
$ 36.56万 - 项目类别:
Regulation of p53 and Checkpoint Signaling by Chromium(VI)
Chromium(VI) 对 p53 和检查点信号传导的调节
- 批准号:
10057383 - 财政年份:2017
- 资助金额:
$ 36.56万 - 项目类别:
相似海外基金
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10590611 - 财政年份:2022
- 资助金额:
$ 36.56万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
- 批准号:
10706006 - 财政年份:2022
- 资助金额:
$ 36.56万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10368975 - 财政年份:2021
- 资助金额:
$ 36.56万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10365254 - 财政年份:2021
- 资助金额:
$ 36.56万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10202896 - 财政年份:2021
- 资助金额:
$ 36.56万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10531570 - 财政年份:2021
- 资助金额:
$ 36.56万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10541847 - 财政年份:2019
- 资助金额:
$ 36.56万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10319573 - 财政年份:2019
- 资助金额:
$ 36.56万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10062790 - 财政年份:2019
- 资助金额:
$ 36.56万 - 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
- 批准号:
DE170100628 - 财政年份:2017
- 资助金额:
$ 36.56万 - 项目类别:
Discovery Early Career Researcher Award